
Endocrinology & Metabolism
WHO Calls for Stronger Safety Monitoring as GLP-1 Use Expands
WHO is calling for stronger safety monitoring as GLP-1 use for weight loss grows worldwide. Clinicians need reliable prescribing, follow-up and adverse-event reporting systems.
Dr. Abu Bakar · September 20, 2026 · 7 min
